Search results for "TPA"

showing 10 items of 770 documents

Novel missense mutation in the ATP1A2 gene associated with atypical sporapedic hemiplegic migraine

2019

Hemiplegic migraine (HM) is a rare subtype of migraine with aura in which attacks include transient motor weakness or hemiparesis that can last several days. HM is linked to mutations in three different genes, CACNA1A, ATP1A2 and SCN1A, which encode for ion transporters. The clinical spectrum includes atypical symptoms such as impaired consciousness, epileptic seizures, permanent cerebellar ataxia or mental retardation. We describe a novel mutation found in the ATP1A2 gene in a patient with late-onset HM. His attacks were characterised by motor weakness associated with altered mental status, diplopia and ataxia. He also showed up MRI abnormalities and incomplete response to prophylactic the…

MaleWeaknessPediatricsmedicine.medical_specialtyAtaxiaNeurologyMigraine with AuraMutation MissenseNeuroimagingneuro geneticsDiagnosis Differential03 medical and health sciences0302 clinical medicineRare DiseaseATP1A2medicineHumansMissense mutationgenetic screening / counselling030212 general & internal medicineMigraineAgedNeurologic ExaminationGenetic counsellingCerebellar ataxiabusiness.industryHeadacheGeneral MedicineMagnetic Resonance ImagingMigraine with auraPedigreeHemiparesisNeurologySettore MED/26 - NeurologiaSodium-Potassium-Exchanging ATPasemedicine.symptombusinessheadache (including migraines)030217 neurology & neurosurgery
researchProduct

Tormogen cell and receptor-lymph space in insect olfactory sensilla. Fine structure and histochemical properties in Calliphora.

1978

(1) The basiconic sensilla on the antennae of Calliphora resemble other insect epidermal sensilla; one or several bipolar sense cells are surrounded by three non-neural cells. (2) The apical cell membrane of the tormogen cell (one of the three accessory cells) forms microvilli coated internally with particles. (3) In the (extracellular) outer receptor-lymph space hyaluronic acid can be demonstrated histochemically. (4) Demonstration of non-specific alkaline phosphatase, Mg2+-activated ATPase, and the presence of mitochondria in the apical part of the tormogen cell suggest active transport processes through these cells into the outer receptor-lymph space.

Maleanimal structuresHistologyATPasemedia_common.quotation_subjectCellApical cellInsectCalliphoraPathology and Forensic MedicinemedicineExtracellularAnimalsHyaluronic Acidmedia_commonAdenosine TriphosphatasesbiologyChemistryHistocytochemistryDipterafungiCell Biologybiology.organism_classificationAlkaline PhosphataseChemoreceptor CellsCell biologymedicine.anatomical_structureUltrastructurebiology.proteinAlkaline phosphataseFemaleEpidermisCell and tissue research
researchProduct

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multi…

2020

Abstract Aims To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban. Methods and results We conducted a prospective multicentre single-arm investigator initiated and academically sponsored management trial in patients with acute low-risk PE (EudraCT Identifier 2013-001657-28). Eligibility criteria included absence of (i) haemodynamic instability, (ii) right ventricular dysfunction or intracardiac thrombi, and (iii) serious comorbidities. Up to two nights of hospital stay were permitted. Rivaroxaban was given at the approved dose for PE for ≥3 months. The primary outcome was sympto…

Malehome treatmentpulmonary embolismrisk stratification030204 cardiovascular system & hematology0302 clinical medicineRivaroxabanRecurrenceRisk FactorsOutpatientsMedicineProspective StudiesRight ventricular dysfunctionEarly dischargeAged 80 and overeducation.field_of_studyHome treatmentriskinarviointiMiddle AgedEUROPEAN-SOCIETYPatient DischargeINPATIENT TREATMENT3. Good healthPulmonary embolismTreatment OutcomeHOSPITALIZATIONAmbulatoryright ventricular dysfunctionFemaleCardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyAdolescentmanagement trialpotilaan kotiuttaminenkotihoitoPopulationDrug Administration Schedule03 medical and health sciencesYoung AdultInternal medicineMANAGEMENTkliiniset kokeetHumansseurantaddc:610Home treatment; Management trial; Pulmonary embolism; Right ventricular dysfunction; Risk stratification; RivaroxabaneducationRisk stratificationAgedRivaroxabanbusiness.industryManagement trial030229 sport sciences3126 Surgery anesthesiology intensive care radiologymedicine.diseaseInterim analysisOUTPATIENT TREATMENTConfidence intervalhyytymisenestohoitoClinical trialTHROMBOSIS3121 General medicine internal medicine and other clinical medicinelääkehoitosydän- ja verisuonitauditveritulppabusinessPulmonary EmbolismFactor Xa InhibitorsEuropean heart journal
researchProduct

Walking Training and Functioning Among Elderly Persons With Stroke: Results of a Prospective Cohort Study.

2014

Abstract Objective To determine if 65- to 85-year-old persons who had a stroke within the previous 3-36 months can improve functioning and quality of life during walking rehabilitation. Design Prospective cohort study with 6-month follow-up. Setting Three inpatient rehabilitation centers and one outpatient rehabilitation center. Participants A total of 147 persons who had sustained a stroke. Intervention The multidisciplinary rehabilitation intervention consisted of inpatient (20 days) or outpatient (18 days) rehabilitation with follow-up. Rehabilitation included walking exercises with and without body-weight support and conventional physiotherapy. After the rehabilitation period, participa…

Malemedicine.medical_specialtyActivities of daily livingTime Factorsmedicine.medical_treatmentPoison controlwalking exercisesPhysical Therapy Sports Therapy and RehabilitationWalkingPhysical medicine and rehabilitationActivities of Daily LivingmedicineOutpatient clinicHumansProspective StudiesProspective cohort studyStrokeAgedAged 80 and overRehabilitationCognitive Behavioral Therapybusiness.industryRehabilitationStroke Rehabilitationta3141medicine.diseaseFunctional Independence MeasureExercise TherapyStrokeTreatment OutcomeNeurologyelderly personsBerg Balance ScalePhysical therapyFemaleNeurology (clinical)businessFollow-Up StudiesPMR : the journal of injury, function, and rehabilitation
researchProduct

ATP4A autoimmunity in pediatric patients with type 1 diabetes and its relationship to blood count, iron metabolism, and vitamin B12

2017

Objective We aimed to assess the prevalence of autoantibodies against the 4A subunit of the gastric proton pump (ATP4A) in pediatric type 1 diabetes (T1D) patients and explore the relationship between ATP4A positivity and blood cell count, iron turnover, and vitamin B12 concentration. Subjects The study included 94 (59% female) T1D children (aged 12.5 ± 4.1 years, T1D duration 4.2 ± 3.6 years, HbA1c 7.3 ± 1.5% (57 ± 12.6 mmol/mol) with no other autoimmune diseases. Methods ATP4A antibodies were measured in T1D patients using a radioimmunoprecipitation assay. Blood cell count, iron concentration, total iron binding capacity, ferritin, transferrin, hepcidin, and vitamin B12 concentration were…

Malemedicine.medical_specialtyAdolescenttype 1 diabetesEndocrinology Diabetes and MetabolismIron030209 endocrinology & metabolismCohort Studies03 medical and health sciencesH(+)-K(+)-Exchanging ATPaseYoung Adult0302 clinical medicineTotal iron-binding capacityHepcidinInternal medicineInternal MedicinemedicineHumansVitamin B12ChildAutoantibodieschemistry.chemical_classificationType 1 diabetesgastric autoimmunitymedicine.diagnostic_testbiologybusiness.industryferritinAutoantibodynutritional and metabolic diseasesIron deficiencyvitamin B12medicine.diseaseBlood Cell CountFerritinVitamin B 12EndocrinologyDiabetes Mellitus Type 1chemistryTransferrin030220 oncology & carcinogenesisChild PreschoolATP4A antibodiesPediatrics Perinatology and Child Healthbiology.proteinFemalebusinessPediatric Diabetes
researchProduct

Insufficient control of heart rate in stable coronary artery disease patients in Latvia

2014

Background and objective:\ud Heart rate (HR) ≥70 beats per minute (bpm) increases cardiovascular risk in coronary artery disease (CAD) patients. The objective of the analysis is to characterize HR as well as other clinical parameters in outpatients with stable CAD in Latvia.<p></p>\ud \ud Materials and methods:\ud CLARIFY is an ongoing international registry of outpatients with established CAD. Latvian data regarding 120 patients enrolled in CLARIFY and collected at baseline visit during 2009–2010 were analyzed.<p></p>\ud \ud Results:\ud The mean HR was 67.7 ± 9.5 and 66.9 ± 10.7 bpm when measured by pulse palpation and electrocardiography, respectively. HR &#8…

Malemedicine.medical_specialtyAdrenergic beta-AntagonistsHeart rateCoronary artery diseaseAngina PectorisNOCoronary artery diseaseElectrocardiographyInternal medicineHeart ratemedicineHumansRegistriesCarvedilolAgedMetoprololHeart FailureMedicine(all)lcsh:R5-920Framingham Risk ScoreCoronary artery disease; Heart rate; Outpatient; Medicine (all)business.industryMedicine (all)OutpatientMiddle Agedmedicine.diseaseLatviaNebivololTreatment OutcomeBisoprololHeart failureAutomotive EngineeringCardiologycardiovascular systemFemalelcsh:Medicine (General)businessHeart rate; Coronary artery disease; Outpatienthuman activitiesmedicine.drugcirculatory and respiratory physiologyMedicina
researchProduct

A Randomized Controlled Trial Assessing the Evolution of the Weight-Bearing Ankle Dorsiflexion Range of Motion Over 6 Sessions of Talus Mobilizations…

2020

Abstract Background Ankle range of motion declines with age, affecting mobility and postural control. Objective The objective of this study was to investigate the effects of a talus mobilization-based intervention among healthy community-dwelling older adults presenting with limited weight-bearing ankle dorsiflexion range of motion and determine how ankle mobility evolved over the treatment. Design This was a randomized clinical trial. Setting This study was conducted in an outpatient clinic. Participants Community-dwelling, older adults over 60 years of age who had limited ankle mobility participated in this study. Interventions The experimental intervention consisted of 6 sessions of manu…

Malemedicine.medical_specialtyAgingPhysical Therapy Sports Therapy and Rehabilitationmedicine.disease_causePatient Positioninglaw.inventionWeight-bearingTalusWeight-Bearing03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationAmbulatory careRandomized controlled triallawAmbulatory CareConfidence IntervalsMedicineOutpatient clinicHumansRange of Motion ArticularAged030222 orthopedicsbusiness.industry030229 sport sciencesMiddle AgedMusculoskeletal ManipulationsConfidence intervalmedicine.anatomical_structureTreatment OutcomeFemaleAnkleManual therapybusinessRange of motionAnkle JointPhysical therapy
researchProduct

Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

2003

Headache attacks and autonomic dysfunctions characterize migraine, a very common, disabling disorder with a prevalence of 12% in the general population of Western countries(1,2). About 20% of individuals affected with migraine experience aura, a visual or sensory-motor neurological dysfunction that usually precedes or accompanies the headache(3). Although the mode of transmission is controversial(4), population-based and twin studies have implicated genetic factors, especially in migraine with aura(5,6). Familial hemiplegic migraine is a hereditary form of migraine characterized by aura and some hemiparesis. Here we show that mutations in the gene ATP1A2 that encodes the alpha2 subunit of t…

Malemedicine.medical_specialtyAuraCell SurvivalPopulationMigraine with AuraMolecular Sequence DataDrug ResistanceBiologyHaploidyTransfectionATP1A2Internal medicineATP1A3Chlorocebus aethiopsGeneticsmedicineAnimalsHumansEnzyme InhibitorseducationOuabainFamilial hemiplegic migraineChromatography High Pressure LiquidGeneticseducation.field_of_studyBase Sequencemedicine.diseaseMigraine with auraPeptide FragmentsPedigreeEndocrinologyMigraineChromosomes Human Pair 1Case-Control StudiesCOS CellsMutationMutagenesis Site-DirectedFemaleCalcium Channelsmedicine.symptomSodium-Potassium-Exchanging ATPaseHaploinsufficiencyHeLa CellsNature genetics
researchProduct

No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in th…

2019

Abstract Background Axial spondyloarthritis (ax-SpA) causes pain, fatigue, stiffness, loss of physical function and impaired health-related quality of life (HRQOL). Aims The study aimed to explore the changes in HRQOL over 5 years in patients with ax-SpA and to identify baseline predictors associated with changes in HRQOL assessed using three HRQOL measures. Methods Demographic, disease, medication and HRQOL data were collected at baseline and at 5-year follow-up. HRQOL was assessed using SF-6D, 15D and SF-36. Analyses involved McNemar, independent paired t tests and multiple regression. Results In the 240 (women 31%, men 69%) ax-SpA patients assessed (mean age 46 years), measures reflectin…

Malemedicine.medical_specialtyBiological treatment erasHealth-related quality of lifePainBiological treatment eraAmbulatory Care FacilitiesArticleHealth related life qualities03 medical and health sciences0302 clinical medicinemedicineHumansOutpatient clinicSpondylitis AnkylosingIn patientAxial spondyloarthritis030212 general & internal medicineAxial spondyloarthritisQuality of Life Research030203 arthritis & rheumatologyHealth related quality of lifebusiness.industryPublic healthPublic Health Environmental and Occupational HealthMiddle Aged5 yearshumanitiesPeer reviewFamily medicineQuality of LifeFemalebusinessFive year periods
researchProduct

Characteristics of patients seeking outpatient smoking cessation treatment before and after the implementation of a smoke-free law in Valencia (Spain…

2020

ObjectiveExplore potential changes in the characteristics of patients requesting smoking cessation treatment at an outpatient setting in Spain before and after Law 42/2010 was enacted.DesignThis is a cross-sectional study with convenience sampling. The information was obtained from the medical records of patients receiving smoking cessation treatment from January 2008 to December 2014.SettingHospital Clinico Universitario de Valencia.Participants423 patients who sought smoking cessation treatment 36 months before or 48 months after the enactment of the law.ResultsAfter the enactment of a comprehensive smoke-free law in Spain, the patients seeking smoking cessation treatment were older (p=0.…

Malemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentPsychological interventionlcsh:Medicineprimary careOutpatientsEpidemiologymedicineHumans15061704Health policybusiness.industryMedical recordPublic healthpublic healthlcsh:Rhealth policyGeneral MedicineIndividual levelCross-Sectional StudiesSpainLawSmoking cessationepidemiologyFemaleSmoking CessationHealth Services ResearchbusinessDelivery of Health CareBMJ Open
researchProduct